Clinical Trials · NCT06283667
Special Use - Results Surveillance on Long-term Use With Wegovy®
- Phase
- N/A
- Recruitment status
- Active Not Recruiting
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 1,071
- Start date
- Jun 2024
- Locations
- 112 sites, Japan
- Primary endpoint
- Number of Adverse Reactions (ARs)